S0278
(±)-索他洛尔 盐酸盐
≥98% (TLC), powder, β-Adrenoceptor antagonist
别名:
N-[4-[1-羟基-2-（异丙基氨基）乙基]苯基]甲磺酰胺 盐酸盐
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C12H20N2O3S · HCl
化学文摘社编号:
分子量:
308.82
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
213-496-0
MDL number:
产品名称
(±)-索他洛尔 盐酸盐, ≥98% (TLC), powder
InChI key
VIDRYROWYFWGSY-UHFFFAOYSA-N
InChI
1S/C12H20N2O3S.ClH/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17;/h4-7,9,12-15H,8H2,1-3H3;1H
SMILES string
Cl.CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1
assay
≥98% (TLC)
form
powder
color
white to off-white
solubility
H2O: 20 mg/mL
originator
Bayer
Quality Level
Gene Information
human ... ADRB1(153), ADRB2(154), ADRB3(155), KCNH2(3757)
正在寻找类似产品? 访问 产品对比指南
Application
(±)-Sotalol hydrochloride has been used to test its effect on the cardiac action potential (AP) in human hearts. It has also been used as an β- blocker to determine its effect on free intracellular calcium (Ca2+) release and whole-cell currents in mammalian cancer cells.
Biochem/physiol Actions
Potent β-adrenoceptor antagonist; class III antiarrhythmic; prolongs the action potential and increases the refractory period.
Sotalol has a potential to block non-cardioselective β-adrenergic receptors. It acts as an anti-arrhythmic agent and is used as a therapeutic for equine arrhythmias. In addition, sotalol also has an ability to stop atrial fibrillation recurrence.
Features and Benefits
This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Bayer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
监管及禁止进口产品
此项目有
Alexander Burashnikov et al.
Circulation. Arrhythmia and electrophysiology, 5(2), 400-408 (2012-02-11)
Several clinical trials have shown that vernakalant is effective in terminating recent onset atrial fibrillation (AF). The electrophysiological actions of vernakalant are not fully understood. Here we report the results of a blinded study comparing the in vitro canine atrial
[QTc-prolongation in acute drug-poisoning. Guidelines for management from the Swedish Poisons Information Centre].
Jonas Höjer
Lakartidningen, 110(19-20), 953-955 (2013-06-12)
Kyle A Arsenault et al.
The Cochrane database of systematic reviews, 1(1), CD003611-CD003611 (2013-02-27)
Atrial fibrillation is a common post-operative complication of cardiac surgery and is associated with an increased risk of post-operative stroke, increased length of intensive care unit and hospital stays, healthcare costs and mortality. Numerous trials have evaluated various pharmacological and
László Drimba et al.
Journal of cardiovascular pharmacology, 60(2), 208-218 (2012-05-25)
High-fat diet and consequent metabolic syndrome (MS) can lead to elevated risk for cardiac arrhythmias. This preclinical study was to investigate if cicletanine (CIC) could produce cardioprotective effects in conscious rabbits exhibiting the main symptoms of MS. NZW rabbits that
Mathias Baumert et al.
PloS one, 7(7), e41920-e41920 (2012-08-04)
Increased beat-to-beat variability in the QT interval (QTV) of ECG has been associated with increased risk for sudden cardiac death, but its measurement is technically challenging and currently not standardized. The aim of this study was to investigate the performance
商品
DISCOVER Bioactive Small Molecules for Neuroscience
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持